Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Barkholt L, Alici E, Conrad R, Sutlu T, Gilljam M, Stellan B, Christensson B, Guven H, Björkström NK, Söderdahl G, Cederlund K, Kimby E, Aschan J, Ringdén O, Ljunggren HG, Dilber MS.
Barkholt L, et al. Among authors: dilber ms.
Immunotherapy. 2009 Sep;1(5):753-64. doi: 10.2217/imt.09.47.
Immunotherapy. 2009.
PMID: 20636021
Clinical Trial.